Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Pilot/Phase I and Phase II Clinical Trial of NG101m Adjuvant Therapy in Newly Diagnosed Glioblastoma Patients

NCT04373785 is registered in ClinicalTrials.gov with NeuGATE Theranostics as lead sponsor.

NCT NCT04373785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04373785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Pilot/Phase I and Phase II Clinical Trial of NG101m Adjuvant Therapy in Newly Diagnosed Glioblastoma Patients
Lead sponsor
NeuGATE Theranostics
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
January 1, 2027
Completion date
December 31, 2030
Enrollment
52 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme